Best of Lung Cancer Conference 2025
Event Landscape
Chaired by Dr. Paul Wheatley-Price and Dr. Vishal Navani, the Best of Lung Cancer Conference 2025 offers Canadian oncology professionals a unique opportunity to stay current on the most impactful lung cancer data and treatment advances presented at ASCO® and ESMO 2025 congresses. Expert speakers will distill key trials and clinical findings into actionable insights, helping clinicians integrate new standards of care and diagnostic tools into their practice. This conference is essential for staying at the forefront of lung cancer treatment and enhancing patient outcomes with the most current, evidence-based practices.
Learning Objectives
- Evaluate uncommon thoracic malignancies relevant to lung cancer practice, including mesothelioma, large cell neuroendocrine carcinoma, and thymic epithelial tumors.
- Explore emerging innovations in lung cancer management, with a focus on robotic-assisted surgery, stereotactic body radiation therapy (SBRT), and the clinical application of antibody-drug conjugates (ADCs).
- Analyze recent advances and evolving standards of care in HER2-driven and other molecular subtypes of lung cancer, emphasizing personalized treatment approaches.
Learning Objectives
- To discuss the pivotal oncology trials presented in the different disease sites
- To review the current standard of care for key malignancies
- To discuss the current controversies in the management of specific cancers
Event Co-Chairs
Dr. Paul Wheatley-Price
BSc, MBChN, FRCP (UK), MD
Dr. Paul Wheatley-Price is Associate Professor in the Department of Medicine at the University of Ottawa, and a medical oncologist at The Ottawa Hospital Cancer Centre, specializing in the treatment of thoracic malignancies and carcinoma of unknown primary.
Dr. Wheatley-Price is a Past President and ongoing Board member for Lung Cancer Canada. Dr. Wheatley-Price attended medical school in the UK, at the University of St. Andrews (1991-1994) and the University of Manchester (1994 – 1997).
He received specialist medical oncology training in Wellington, New Zealand, in London at the Royal Free Hospital, Guy’s and St. Thomas’ Hospitals and St. George’s Hospital, and as a Fellow in Lung Cancer Research at Princess Margaret Cancer Centre in Toronto.
He has been in Ottawa since 2009.
Dr. Vishal Navani
MA (Oxon), MBBS, MRCP, FRACP
Dr. Vishal Navani is a staff medical oncologist at the Tom Baker Cancer Centre and an Assistant Professor (Clinical) at the University of Calgary. He previously graduated from Oxford and Imperial College London. He holds both Membership of the Royal College of Physicians of the United Kingdom and Fellowship of the Royal Australasian College of Physicians.
His academic focus includes the interrogation of large real world datasets spanning tumour streams in order to generate practical insights that can be used in the clinic. He treats patients with thoracic and GU malignancies. He is the principal director of Glans Look Research, one of North America’s largest lung cancer databases. He leads the Thoracic Oncology residency training programme at the University of Calgary and mentors dozens of undergraduate and post-graduate learners.
His work includes over 60 manuscripts and abstracts and has been published extensively in high impact journals, including JAMA Oncology, European Urology and an upcoming editorial in the Lancet Oncology. He is a peer reviewer for the JCO and on the editorial board of Therapeutic Advances in Medical Oncology. He has won competitive Canadian grant funding and international awards including ASCO Merit awards. He plays a lead role in academic endeavours at the University of Calgary such as the Precision Oncology and Experimental Therapeutics initiative and has contributed as a clinical expert to CADTH national drug reimbursement decisions.
Registrant Accommodations
As a registrant of the 19th Canadian Melanoma Conference we are pleased to offer you the CMC discounted room rate for your stay between February 16 – 26, 2025. Reservations will be accepted up to January 17, 2025 and will sell out quickly.
Abstract Submission Guidelines & Requirements
Residents, Students and fellows are invited to submit an abstract of their research between September 22 and November 22, 2024. All selected poster presenters (Lead Author) will have their conference registration fee waived. The reviewing committee will select 5 abstracts from those submitted for oral presentation; the latter is scheduled for in-person poster presentation at the Canadian Melanoma Conference in Vancouver, BC. One author for each of the 5 selected abstracts will receive a $3,000 CAD honorarium to assist with accommodations and travel to and from the conference.
2024 Important Dates:
Submission Opens: Sunday, September 22, 2024
Submission Deadline: Friday, November 22, 2024
Notification Sent to Lead Author: Friday, November 29, 2024
Please refer to the attachment linked below for submission guidelines and requirements.
Guidelines:
Sponsorship
For sponsorship-related inquiries, please contact your Director of Strategic Partnerships or visit our website
GOLD SPONSORS
SILVER SPONSORS
All sales are final, refunds will not be accepted.
Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.
Please be advised that video and photo recording will take place during this event. By registering and attending, you consent to being photographed and filmed. These materials may be used for promotional purposes, including but not limited to social media, websites, and other communication channels. If you have any concerns or wish to discuss this further, please contact us at [email protected] before the event.
